Long-term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients.

The long-term outcomes of sensitized recipients who underwent desensitization are encouraging. Adding rituximab to PP + IVIG in candidates with very high titers may result in improved outcome.